Lexeo Therapeutics, Inc.

Q2 2025 13F Holders

Symbol
LXEO
CUSIP
52886X107
Type
Equity
Class
COM
Num filings
92
Total reported value, excl. options
$170 M
Manager Report Date Value ($000) Shares Option Type